Skip to content

Pain Mechanisms in Patients With Bronchiectasis

Characteristics of Underlying Pain Mechanisms in Patients With Bronchiectasis: a Cross-sectional Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03376204
Enrollment
0
Registered
2017-12-18
Start date
2017-09-29
Completion date
2019-11-30
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Respiratory Disease

Keywords

Bronchiectasis, Pain mechanisms, Pressure pain threshold, Referred pain

Brief summary

Pain mechanisms and their clinical impact in patients with bronchiectasis have not been investigated yet. The aim of the research is to assess the presence of central pain mechanisms in patients with bronchiectasis using the Quantitative Sensory Testing (QST) assumptions.

Detailed description

Background and objective: Recent findings suggest that pain can play an important role in terms of physical activity limitation in respiratory patients. Nevertheless, pain mechanisms and their clinical impact in patients with bronchiectasis have not been investigated yet. The objective of the observational study is to determine the somatosensorial profile in order to assess the presence of central pain mechanisms in patients with bronchiectasis. Methodology: Repeated-measures prospective cross-sectional study. A sample of patients diagnosed with bronchiectasis will be recruited and matched by age and sex with healthy controls. Pressure pain thresholds (PPTs), conditioned pain modulation (CPM) and referral pain will be assessed before and after the Incremental Shuttle Walking test (ISW). Levels of physical activity will be assessed using accelerometry during a 7-days period. Sleep quality (Pittsburgh sleep quality test), level of catastrophizing (Pain Catastrophizing Scale), level of sensitization (Central Sensitization Inventory) and level of anxiety and depression (Hospital Anxiety and Depression) will be assessed. The assessments will be done twice: 1) at baseline; and 2) at 6 months follow-up period.

Interventions

OTHERNo intervention

No intervention

Sponsors

Universidad San Jorge
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

Bronchiectasis Group Inclusion Criteria: * Diagnosis of bronchiectasis by high-resolution computed tomography. * Ability to understand and perform all the clinical procedure. * Acquisition of informed consent.

Exclusion criteria

* Diagnosis or clinical suspicion of cystic fibrosis by genetic test or sweat electrolytes test. * Diagnosis of rheumatic disease. * Being on a waiting list for lung transplantation. * Thoraco-abdominal surgery in the last 6 months. * Chronic use of pain medication. Control Group Inclusion Criteria: * Healthy subjects matched by age and sex with Bronchiectasis Group's subjects

Design outcomes

Primary

MeasureTime frameDescription
Referred pain areaBaselineAmount of pixels painted in an electronic body chart (Navigate Pain, Aalborg, Denmark) after supra threshold pain stimulus (STPS) in infraspinatus muscle.

Secondary

MeasureTime frameDescription
Pain intensity after supra threshold pain stimulus (STPS)BaselineLevel of pain in a visual analogue scale from 0 to 10 after STPS
Pressure pain thresholds (PPTs)BaselineLevel of pressure tolerated by the patient just before feel pain. The pressure is done with an algometer (SB-MEDIC Electronics, Solna, Sweden). PPTS will be assessed bilaterally in infraspinatus, supraspinatus and medial gastrocnemius muscles.
PPTs with a Conditioned Pain Modulation (CPM) pressure stimulusBaselineLevel of pressure tolerated by patient just before feel pain. The conditionated pressure stimulus is preform by a blood pressure cuff. CPM will be assessed bilaterally in infraspinatus, supraspinatus and medial gastrocnemius muscles.
Total physical activity time7 days periodTotal time spent per day in physical activities at different intensities equal or superior to 100 counts per minute (≥100 cpm), obtained by accelerometry (Actigraph gt3x+).
Sedentary behaviour time7 days periodTotal time spent per day in physical activities at different intensities inferior to 100 cpm (\<100 cpm).
Light physical activity time7 days periodTotal time spent per day in physical activities at intensities between 100 and 1951 cpm (100-1951 cpm).
Moderate-Vigorous physical activity time7 days periodTotal time spent per day in physical activities at intensities equal or superior to 1952 cpm (≥1952 cpm).
Level of catastrophizingBaselinePunctuation obtained in Pain Catastrophizing Scale (PCS). It comprises 13 items which focus on thoughts and feelings encountered while experiencing pain. Each item is scored from 0 (not at all) to 4 (all the time) with a total PCS score range from 0-52 points, where higher scores indicating higher levels of pain catastrophizing.
Level of sensitizationBaselinePunctuation obtained in Central Sensitization Inventory (CSI). CSI assesses 25 health-related symptoms common to Central Sensitivity Syndromes. Responses are recorded about the frequency of each symptom, with a Likert scale from 0 (never) to 4 (always), resulting in a total possible score of 100. Higher scores are associated with a higher degree of self-reported symptomology.
Number of body areas affected by referred painBaselineBody chart is divided in 15 regions and the frequency of pain in each one is registered after STPS
Quality of sleepBaselinePunctuation obtained in Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19-item, self-rated questionnaire designed to measure sleep quality and disturbance over the past month in clinical populations. Each sleep component yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. Sleep component scores were summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.
Level of resilienceBaselinePunctuation obtained in Brief Resilience Scale (BRS). This is a 6-item self-report scale with a 5-point response scale ranging from 1 (strongly disagree) to 5 (strongly agree). A higher score indicates a higher degree of resilience.
Distance in ISW testBaselineMeters reached in the ISW test.
Changes in referred pain areaBaseline and after 6 months follow-upAmount of pixels painted in an electronic body chart (Navigate Pain, Aalborg, Denmark) after supra threshold pain stimulus (STPS) in infraspinatus muscle.
Changes in number of body areas affected by referred painBaseline and after 6 months follow-upBody chart is divided in 15 regions and the frequency of pain in each one is registered after STPS
Changes in pain intensity after supra threshold pain stimulus (STPS)Baseline and after 6 months follow-upLevel of pain in a visual analogue scale from 0 to 10 after STPS.
Changes in pressure pain thresholds (PPTs)Baseline and after 6 months follow-upLevel of pressure tolerated by the patient just before feel pain. The pressure is done with an algometer (SB-MEDIC Electronics, Solna, Sweden)
Changes in Pressure Pain Thresholds (PPTs) with a Conditioned Pain Modulation (CPM) pressure stimulusBaseline and after 6 months follow-upLevel of pressure tolerated by patient just before feel pain. The conditionated pressure stimulus is preform by a blood pressure cuff
Level of anxiety and depressionBaselinePunctuation obtained in Hospital Anxiety and Depression (HAD). The HAD is a 14-item self-report scale measuring the presence of symptoms of both anxiety (seven items) and depression (seven items) during the past week. Each item is scored from 0 to 3, so the final score for each subscale is between 0 and 21. The majority of the studies use the cutoffs of 7/8 for possible and 10/11 for probable anxiety or depression.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026